天士力医药集团股份有限公司2025年第六次临时股东会决议公告

Group 1 - The sixth extraordinary general meeting of shareholders of Tasly Pharmaceutical Group Co., Ltd. was held on December 26, 2025, with no resolutions rejected [2] - The meeting was conducted in compliance with relevant laws and regulations, utilizing both on-site and online voting methods [2][3] - All proposed resolutions were passed, including the cancellation of the supervisory board and amendments to the company's articles of association [3][4] Group 2 - The meeting included the approval of several governance documents, such as the rules for shareholder meetings and board meetings [4] - The company plans to engage in expected daily operational related transactions with China Resources (Group) Co., Ltd. and its subsidiaries in 2026, which were also approved [4][5] - The company has changed its email address for investor communication from stock@tasly.com to stock@taslypharma.com, effective immediately [8]